Nuvation Bio
NUVB
119 hedge funds and large institutions have $503M invested in Nuvation Bio in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 47 reducing their positions, and 17 closing their positions.
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
2% more funds holding
Funds holding: 117 → 119 (+2)
1.51% less ownership
Funds ownership: 73.01% → 71.5% (-1.5%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
40% less capital invested
Capital invested by funds: $837M → $503M (-$334M)
43% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$45M |
| 2 |
E
Ergoteles
New York
|
+$2.22M |
| 3 |
6CM
683 Capital Management
New York
|
+$2.12M |
| 4 |
Millennium Management
New York
|
+$2.06M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$33.6M |
| 2 |
DM
Deerfield Management
New York
|
-$18.8M |
| 3 |
BlackRock
New York
|
-$4.89M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$3.41M |
| 5 |
Goldman Sachs
New York
|
-$2.49M |
NUVB Hedge Fund Activity: Q2 2022 in Review
119 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q2 2022, worth a combined $503M — down 40% from $837M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NUVB positions and 17 closed out — a net gain of 4 holders — while 27 added to existing stakes and 47 trimmed.
The largest buyer was Deep Track Capital, adding an estimated $45M. The largest seller was Omega Fund Management, cutting an estimated $33.6M.
- 119 institutional investors held Nuvation Bio (NUVB) as of Q2 2022, up from 117 in Q1 2022.
- Funds reported $503M of Nuvation Bio stock for Q2 2022, down 40% quarter-over-quarter.
- 21 funds opened new Nuvation Bio positions in Q2 2022 and 17 closed out, a net change of +4 holders.
- The largest Nuvation Bio buyer in Q2 2022 was Deep Track Capital, an estimated $45M added.
- The largest Nuvation Bio seller in Q2 2022 was Omega Fund Management, an estimated $33.6M sold.
Based on aggregated 13F filings for Q2 2022.